Filing Details

Accession Number:
0001209191-12-042906
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-22 18:31:57
Reporting Period:
2012-08-20
Filing Date:
2012-08-22
Accepted Time:
2012-08-22 18:31:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243399 Jr A Woodrow Myers Myers Ventures Llc
1 North Illinois Street 2101
Indianapolis IN 91362
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-20 5,507 $9.95 7,743 No 4 M Direct
Common Stock Disposition 2012-08-20 5,507 $35.06 2,236 No 4 S Direct
Common Stock Acquisiton 2012-08-21 10,993 $9.95 13,229 No 4 M Direct
Common Stock Disposition 2012-08-21 10,993 $35.28 2,236 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (right to buy) Disposition 2012-08-20 5,507 $0.00 5,507 $9.95
Common Stock Director Stock Option (right to buy) Disposition 2012-08-21 10,993 $0.00 10,993 $9.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,993 2016-04-11 No 4 M Direct
0 2016-04-11 No 4 M Direct
Footnotes
  1. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  2. Represents weighted average sale price. Actual sale prices ranged from $35.00 to $35.21.
  3. Represents weighted average sale price. Actual sale prices ranged from $35.21 to $35.54.
  4. The option became exercisable as to 25% of the shares on April 11, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.